Diagnostics & Diseases Market Research Reports & Industry Analysis

Publications found: 54,468
Sort by:

2014 Analysis of the Respiratory Syncytial Virus Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Landscape

US$ 3,480.00

The report presents a detailed analysis of the Respiratory Syncytial Virus diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. ... , the report presents sales and market share estimates for major suppliers of Respiratory Syncytial Virus tests. Also, the report examines the market ...

November 2013 227 pages

2014 Analysis of the RhinovirusTesting Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Country Forecasts, Innovative Technologies, Competitive Landscape

US$ 3,480.00

The report presents a detailed analysis of the Rhinovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Rhinovirus definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts ...

November 2013 194 pages

2014 Analysis of the Rotavirus Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Landscape

US$ 3,480.00

The report presents a detailed analysis of the Rotavirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific ... the report presents sales and market share estimates for major suppliers of Rotavirus tests. Also, the report examines the market applications of DNA ...

November 2013 205 pages

2014 Analysis of the Rubella Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Landscape

US$ 3,480.00

The report presents a detailed analysis of the Rubella diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views ... report presents sales and market share estimates for major suppliers of Rubella tests. Also, the report examines the market applications of DNA ...

November 2013 235 pages

2014 Analysis of the Salmonella Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Landscape

US$ 3,480.00

The report presents a detailed analysis of the Salmonella diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific ... report presents sales and market share estimates for major suppliers of Salmonella tests. Also, the report examines the market applications of DNA ...

November 2013 221 pages

2014 Analysis of the Septicemia Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Landscape

US$ 3,480.00

The report presents a detailed analysis of the Septicemia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific ... report presents sales and market share estimates for major suppliers of Septicemia tests. Also, the report examines the market applications of DNA ...

November 2013 202 pages

2014 Analysis of the Shigella Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Landscape

US$ 3,480.00

The report presents a detailed analysis of the Shigella diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views ... report presents sales and market share estimates for major suppliers of Shigella tests. Also, the report examines the market applications of DNA ...

November 2013 220 pages

2014 Analysis of the Streptococci Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Landscape

US$ 3,480.00

The report presents a detailed analysis of the Streptococci diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific ... presents sales and market share estimates for major suppliers of Streptococci tests. Also, the report examines the market applications of DNA ...

November 2013 205 pages

2014 Analysis of the Syphilis Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Landscape

US$ 3,480.00

The report presents a detailed analysis of the Syphilis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views ... report presents sales and market share estimates for major suppliers of Syphilis tests. Also, the report examines the market applications of DNA ...

November 2013 231 pages

2014 Analysis of the Thrombin Time Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Country Forecasts, Innovative Technologies, Competitive Landscape

US$ 3,480.00

... , creating additional opportunities and challenges for suppliers. This report presents a detailed analysis of the Thrombin Time testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well ...

November 2013 196 pages

2014 Analysis of the Tuberculosis Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Landscape

US$ 3,480.00

The report presents a detailed analysis of the Tuberculosis diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific ... presents sales and market share estimates for major suppliers of Tuberculosis tests. Also, the report examines the market applications of DNA ...

November 2013 208 pages

2014 Analysis of the Vibrio Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Country Forecasts, Innovative Technologies, Competitive Landscape

US$ 3,480.00

The report presents a detailed analysis of the Vibrio diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Vibrio definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test ...

November 2013 200 pages

2014 Analysis of the Yersinia Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Country Forecasts, Innovative Technologies, Competitive Landscape

US$ 3,480.00

The report presents a detailed analysis of the Yersinia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Yersinia definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by ...

November 2013 197 pages

Physician Views: Entering the post-interferon era – will Gilead Sciences dominate hepatitis C?

US$ 695.00

... currently anticipated for AbbVie. To gain a better perspective on how physicians expect to use interferon-free regimens, FirstWord is polling gastroenterologists/hepatologists and infectious ... of genotype 1 patients they would prescribe an interferon-sparing, once-daily, single-tablet therapy rather than an interferon-sparing multi-tablet therapy dosed ...

November 2013 -

2014 Transfusion Diagnostic Testing Market: Strategic Assessments of Major Suppliers

US$ 1,480.00

This report presents extensive analyses of major current and emerging suppliers of transfusion diagnostic instruments and reagents. For each company the report provides: Sales Market shares Product portfolios Marketing tactics Technological know-how New ...

November 2013 50 pages

2014 Analysis of the POC Lipid Testing Market: US, Germany, Spain Physician Offices, Emergency Rooms, Ambulatory Care Centers

US$ 3,480.00

... from Venture Planning Group contains 36 tables, and provides a comprehensive analysis of the POC lipid testing market, including trends, dynamics, size, growth, ... appeal during the next five years. Design criteria for POC testing products. Alternative business expansion strategies. Potential market entry ...

November 2013 340 pages

2014 Tumor Markers Testing Market: Strategic Assessments of Major Suppliers

US$ 2,000.00

This new 80-page report from Venture Planning Group provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents. The assessments include: Sales Product portfolios Distribution tactics Technological know-how New products in R&D Collaborative ...

November 2013 80 pages

2014 Microbiology Testing Market: Strategic Assessments of Leading Strategic Suppliers

US$ 1,480.00

This report presents strategic assessments of leading market players and emerging suppliers with innovative technologies and products in terms of their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Contains ...

November 2013 90 pages

2014 Coagulation Testing Market: Strategic Assessments of Major Suppliers

US$ 2,000.00

This report presents analyses of major current and emerging suppliers of coagulation products in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Contains 45 pages

November 2013 45 pages

2014 Hematology and Flow Cytometry Market: Strategic Assessments of Major Suppliers

US$ 1,480.00

This report presents strategic analyses of the major current and emerging suppliers in terms of their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Contains 30 pages

November 2013 30 pages

Physician Views: Oncologist reaction to Roche's Gazyva – US approval and new late-stage data versus Rituxan

US$ 695.00

... for Gazyva are ongoing. This week’s FirstWord Physician Views poll aims to gauge initial oncologist reaction to the data for, and approval of, Gazyva and ... uptake will occur in the first-line CLL setting. Specifically oncologists based in the US and EU5 will be asked: What percentage of chronic ...

November 2013 -

2014 Analysis of the Tumor Markers: US, Europe, Japan - Emerging Opportunities and Business Expansion Strategies for Suppliers

US$ 22,800.00

... : Biochemical Markers Oncogenes Growth Factors Hormones Colony Stimulating Factors Lymphokines Immunohistochemical Stains, and others. Analysis of major immunoassay analyzers used for tumor marker testing, including their operating characteristics, features and selling prices. Technology Review ...

November 2013 1200 pages

2014 Analysis of the Tumor Marker Testing Market in Europe: Market Segment Forecasts and Supplier Shares

US$ 15,760.00

... and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for ...

November 2013 820 pages

2014 Analysis of the European HIV/AIDS Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs - Supplier Shares and Sales Forecasts For Immunodiagnostic and NAT Procedures

US$ 3,160.00

... DataPack (test volumes, sales forecasts, supplier shares) $2,500. Summary This 5-country report presents detailed analyses of the AIDS diagnostics market in Europe (France, Germany, Italy, Spain, UK). For each country, the report provides test volume and sales forecasts for HIV-1/2, HIV Ag, NAT, Western ...

November 2013 277 pages

2014 Analysis of the US Hepatitis Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices - Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures

US$ 3,120.00

Complete report $3,900. DataPack (test volumes, sales forecasts, supplier shares) $2,500. The report presents a detailed analysis of the Hepatitis diagnostics market in the US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test ...

November 2013 241 pages

2014 Analysis of the European Hepatitis Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices - Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures

US$ 5,520.00

Complete report $6,900. DataPack (test volumes, sales forecasts, supplier shares) $4,500. The report presents a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. ...

November 2013 295 pages

2014 Analysis of the European Pap Smear/HPV Market

US$ 2,280.00

... . DataPack (test volumes, sales forecasts) $1,850. This report presents a detailed analysis of the Pap Smear/HPV testing market in Europe (France, Germany, Italy, Spain, UK), including clinical significance and current laboratory practice; as well as five-year test volume ...

November 2013 235 pages

2014 Analysis of the US Cell Surface Marker Testing Market: Hospitals, Commercial Labs, Ambulatory Care Centers, Physician Offices

US$ 1,800.00

... . During the next ten years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the analysis itself. This report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in the US, including clinical significance and ...

November 2013 115 pages

2014 Analysis of the European Cell Surface Marker Testing Market: Hospitals, Commercial Labs, Ambulatory Care Centers

US$ 3,080.00

... $2,500. The report provides an overview of the cell surface marker testing in Europe (France, Germany, Italy, Spain, UK), including 5-year forecasts for CD4, CD8 ... and the analysis itself. This report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in five European countries ...

November 2013 125 pages

2014 Analysis of the Emerging US Point-of-Care Testing Market: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers

US$ 10,000.00

... Drugs of Abuse TDM Endocrine Function Tumor Markers Sales and Market Share Analysis Sales and market shares of major reagent and instrument suppliers. Current and Emerging Products Analysis of over 130 diagnostic procedures. Review of the leading POC chemistry, immunoassay ...

November 2013 1007 pages

2014 Analysis of the Diagnostic Testing Market US Ancillary Hospital Locations (ER, OR, ICU)

US$ 10,000.00

... 973-page report contains 153 tables and provides comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ... instrument and consumable suppliers. We trust, this report will help diagnostic products suppliers develop more effective business, R&D and marketing strategies. ...

November 2013 973 pages

2014 Analysis of the Diagnostic Testing Market US Physician Offices and Group Practices: Supplier Shares and Sales Forecasts for Over 300 Tests

US$ 10,000.00

... Sales and Market Share Analysis Sales and market shares of major reagent and instrument suppliers. Current and Emerging Products Analysis of over 130 diagnostic procedures. Review of leading chemistry, immunoassay, hematology and coagulation analyzers, both currently marketed and those in development, ...

November 2013 970 pages

2014 Analysis of the US Point-of-Care Infectious Disease Diagnostics Market: Physician Offices/Group Practices, Emergency Rooms, Ambulatory Care Centers, Surgery Centers, Birth Centers

US$ 4,400.00

... and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of five POC market segments, including their dynamics, trends, structure, size, growth and major suppliers. Five-year test ...

November 2013 795 pages

2014 Analysis of the US Point-of-Care Hematology and Flow Cytometry Markets: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers

US$ 4,400.00

... from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of nine POC market segments, including their dynamics, trends, ... Centers Nursing Homes Birth Centers Sales and Market Share Analysis Sales and market shares of major hematology and flow cytometry ...

November 2013 238 pages

2014 Analysis of the US Point-of-Care Clinical Chemistry Market: Physician Offices, Emergency Rooms, Operating Suites, ICU/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers

US$ 4,400.00

... from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of nine POC market segments, including their dynamics, trends, ... Centers Nursing Homes Birth Centers Sales and Market Share Analysis Sales and market shares of major clinical chemistry reagent and ...

November 2013 373 pages

2014 Analysis of the US Point-of-Care Coagulation Testing Market: Physician Offices, Emergency Rooms, Operating Suites, ICU/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers

US$ 4,400.00

... hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of nine POC market segments, including their dynamics, trends, ... Centers Nursing Homes Birth Centers Sales and Market Share Analysis Sales and market shares of major coagulation reagent and instrument ...

November 2013 418 pages

2014 Analysis of the US PT and APTT Point-of-Care Testing Market: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers

US$ 2,320.00

... from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of nine POC market segments, including their dynamics, trends ... Centers Nursing Homes Birth Centers Sales and Market Share Analysis Sales and market shares of major reagent and instrument suppliers ...

November 2013 337 pages

2014 Analysis of the POC Lipid Testing Market in the US: Physician Offices, Emergency Rooms, Ambulatory Care Centers

US$ 2,320.00

... from Venture Planning Group contains 22 tables, and provides a comprehensive analysis of the POC lipid testing market, including trends, dynamics, size, growth, ... appeal during the next five years. Design criteria for POC testing products. Alternative business expansion strategies. Potential market entry ...

November 2013 305 pages

2014 Analysis of the US Home/Self Testing Market: Diabetes, Pregnancy, Ovulation, Occult Blood Business Challenges and Marketing Strategies for Suppliers

US$ 1,160.00

This new 175-page report from Venture Planning Group provides analysis of the major home/self testing market segments, including diabetes ( ... from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of the home/self testing market segments, including diabetes ( ...

November 2013 175 pages

2014 Analysis of the French Tumor Marker Testing Market: Innovations, Trends and Opportunities for Suppliers

US$ 4,880.00

Highlights Comprehensive 585-page analysis of the French tumor marker testing market. Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality statistics ...

November 2013 585 pages

2014 Analysis of the Italian Tumor Marker Testing Market: Innovations, Trends and Opportunities for Suppliers

US$ 4,880.00

Highlights Comprehensive 570-page analysis of the Italian tumor marker testing market. Major issues pertaining to the Italian laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...

November 2013 570 pages

2014 Analysis of the German Tumor Marker Testing Market: Innovations, Trends and Opportunities for Suppliers

US$ 4,880.00

Highlights Comprehensive 585-page analysis of the German tumor marker testing market. Major issues pertaining to the German laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality statistics ...

November 2013 585 pages

2014 Analysis of the Japanese Tumor Marker Testing Market: Innovations, Trends and Opportunities for Suppliers

US$ 6,000.00

Highlights Comprehensive 590-page analysis of the Japanese tumor marker testing market. Major issues pertaining to the Japanese laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...

November 2013 590 pages

2014 Analysis of the Spanish Tumor Marker Testing Market: Innovations, Trends and Opportunities for Suppliers

US$ 4,880.00

Highlights Comprehensive 565-page analysis of the Spanish tumor marker testing market. Major issues pertaining to the Spanish laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...

November 2013 565 pages

2014 Analysis of the UK Tumor Marker Testing Market: Innovations, Trends and Opportunities for Suppliers

US$ 4,880.00

Complete report $5,400. DataPack (test volumes, sales forecasts, supplier shares) $1,950. Highlights Comprehensive 575-page analysis of the UK tumor marker testing market. Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological ...

November 2013 575 pages

2014 Analysis of the US Tumor Marker Testing Market: Innovations, Trends and Opportunities for Suppliers

US$ 7,760.00

Complete report $8,700. DataPack (test volumes, sales forecasts, supplier shares) $3,450. Highlights Comprehensive 620-page analysis of the US tumor marker testing market. Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological ...

November 2013 620 pages

2014 Analysis of the Nucleic Acid Testing in Europe: Market Segment Forecasts and Supplier Shares

US$ 15,760.00

This comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years. The report explores business and technological trends in major European ...

November 2013 970 pages

2014 Analysis of the Global Nucleic Acid Testing Market: Innovative Technologies and Emerging Business Opportunities

US$ 22,800.00

... -year test volume and sales projections by country. Market Segmentation Analysis Sales and market shares of major suppliers of NAT reagent kits ... volume and sales projections for over 30 NAT assays. A comprehensive analysis of the sequencing market, by country and laboratory segment, including: Industrial ...

November 2013 1050 pages

2014 Analysis of the German Nucleic Acid Testing Market: Innovations, Trends and Opportunities for Suppliers

US$ 5,360.00

Highlights Comprehensive 850-page market segmentation analysis of the German NAT market. Major issues pertaining to the German NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact ...

November 2013 850 pages

2014 Analysis of the Italian Nucleic Acid Testing Market: Innovations, Trends and Opportunities for Suppliers

US$ 5,360.00

Highlights Comprehensive 850-page market segmentation analysis of the Italian NAT market. Major issues pertaining to the Italian NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. An ...

November 2013 850 pages

Filters

Search

Categories

268
192
109
61
115
177
506
57
186
740
1,080
151
42,070
1,037
1,323
85
1,850
4,362
99

Publishers

344
2,069
197
1
335
52
47
127
51
4
91
490
83
3
22
2
1
3
8
15
28
1
1
317
4
1
1
13
2
107
377
3
9
1
2
1
5
16
1
13
40
1
2
16
19
43
2,157
15
65
29
16
4
18
121
39
15
7
2
285
11
22
1
16
22
5
74
46,098
40
2
178
24
91
48
45
49

Regions

200
15
1
137
135
134
134
134
138
138
137
137
137
137
137
137
136
136
136
135
134
131
130
211
194
193
15
105
194
17
175
27,846
442
196
195
195
194
194
194
194
194
194
194
194
193
193
193
193
193
193
193
192
192
192
191
191
191
137
137
4
3
2
204
200
199
199
198
197
197
197
197
197
196
196
196
196
196
196
196
195
195
194
194
194
194
194
193
192
190
188
111
108
107
106
106
214
197
231
232
1,123
1,620
1,213
1,200
1,198
1,180
1,175
1,158
228
204

Price

—

Date

—

Pages

—

Offers

1